News & Publications

Latest News

Donna Ryan Named Executive Director of LSU's Pennington Biomedical Research Center

Released: Thursday, January 26, 2017

BATON ROUGE - LSU President F. King Alexander has announced that Dr. Donna Ryan, a world-renowned obesity researcher and professor emerita at Pennington Biomedical, will serve as interim executive director of LSU's Pennington Biomedical Research Center. Current Executive Director Dr. William Cefalu was recently named chief scientific and medical officer of the American Diabetes Association.

"We are pleased to name Dr. Donna Ryan as the interim executive director at Pennington Biomedical," Alexander said. "She is well-respected among her peers and has the experience to lead Pennington Biomedical during the search for the next executive director. We look forward to working with her to continue the progress Pennington Biomedical has seen under Dr. Cefalu's leadership."

From 1988-2012, Ryan served as an associate professor, professor and as then associate executive director for clinical research at Pennington Biomedical. She currently serves as president-elect of the World Obesity Federation and associate editor in chief of the scientific journals Obesity Research and Obesity.

"Dr. Ryan is an outstanding choice to lead the center during its search for a new executive director," said William Silvia, president & CEO, Pennington Biomedical Research Foundation. "Her interest in obesity research was mentored by Pennington Biomedical's very first executive director Dr. George Bray, and her career has included work on some of the most influential research that has shaped the science. She also has a demonstrated interest in obesity education and mentoring young scientists, in particular, in training primary care physicians to incorporate obesity management into their medical practices. Her insight and guidance are sought the world over and we're fortunate to have her back here at Pennington Biomedical during this important time."

Ryan is a recognized consultant and advisor on the topic of obesity and chronic disease. She has also continued to serve as an active mentor on Pennington Biomedical's Clinical Mentoring Committee. Ryan was instrumental in a number of landmark nutrition, diabetes, weight loss and military health research studies. She has been an author on more than 225 original publications, 11 books, and nearly 50 scholarly chapters and reviews.

"Pennington Biomedical is a long-treasured feather in the cap of LSU and the state of Louisiana," Ryan said. "I know firsthand just how unique and special a place it is. The researchers at Pennington Biomedical and the science they produce has been trusted and relied on for nearly three decades to improve health and nutrition here at home and around the world. I'm truly honored to be asked to return to a place that I love and, with the support of President Alexander, to serve LSU once again."

Pennington Biomedical's mission is to discover the triggers of chronic disease and put science to work for a healthier Louisiana, country and global community. For more information on Pennington Biomedical, visit

Release courtesy of LSU's Division of Strategic Communications -


About the Louisiana Clinical and Translational Science (LA CaTS) Center
The LA CaTS Center is comprised of three primary collaborating institutions in the state, including LSU's Pennington Biomedical Research Center in Baton Rouge, LSU Health Sciences Center in New Orleans, and Tulane University School of Medicine in New Orleans – and also includes six research partners: LSU Health Sciences Center in Shreveport, Louisiana State University in Baton Rouge, and in New Orleans, Xavier University of Louisiana, Children’s Hospital, Ochsner Health System, Southeast Louisiana Veterans Health Care System, and University Medical Center.  The LA CaTS Center’s vision for Louisiana encompasses the strengths and capacities unique to each member institution and represents a unified, comprehensive approach for targeting prevention, care and research of chronic diseases in the underserved population.  The scholar program is supported in part by U54 GM104940 from the National Institute of General Medical Sciences of the National Institutes of Health which funds the Louisiana Clinical and Translational Science Center.  For more information, please visit